M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Middle East Pharmaceutical Industries Company SJSC
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Middle East Pharmaceutical Industries Company SJSC
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Accounts Receivables
ď·Ľ155.5m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
Accounts Receivables
ď·Ľ1.2B
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
3%
J
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Accounts Receivables
ď·Ľ332.1m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Middle East Pharmaceutical Industries Company SJSC
Glance View

Market Cap
2.4B SAR
Industry
Pharmaceuticals

Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.

Intrinsic Value
88.32 SAR
Overvaluation 27%
Intrinsic Value
Price
M

See Also

What is Middle East Pharmaceutical Industries Company SJSC's Accounts Receivables?
Accounts Receivables
155.5m SAR

Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Accounts Receivables amounts to 155.5m SAR.

What is Middle East Pharmaceutical Industries Company SJSC's Accounts Receivables growth rate?
Accounts Receivables CAGR 3Y
12%

Over the last year, the Accounts Receivables growth was 3%. The average annual Accounts Receivables growth rates for Middle East Pharmaceutical Industries Company SJSC have been 12% over the past three years .

Back to Top